Amyloid deposition is delayed in mice with targeted deletion of the serum amyloid P component gene

Botto, Marina, Hawkins, Philip N., Bickerstaff, Maria C.M., Herbert, Jeff, Bygrave, Anne E., Mcbride, Alan, Hutchinson, Winston L., Tennent, Glenys A. +2 more·1997·Nature Medicine
DOI 10.1038/nm0897-855

Cited by (239)

Items 101–200 of 239

  1. The structures of crystalline complexes of human serum amyloid P component with its carbohydrate ligand, the cyclic pyruvate acetal of galactose.
    D. Thompson, M. Pepys, I. Tickle, S. Wood · 2002 · Journal of Molecular Biology
  2. Molecular chaperons, amyloid and preamyloid lesions in the BRI2 gene‐related dementias: a morphological study
    Tammaryn Lashley, Janice L. Holton, Marcel M. Verbeek, Agueda A. Rostagno, M. Bojsen‐Møller, Guido David, Jack van Horssen, Hans Brændgaard, Gordon Terence Plant, Blas Frangione et al. · 2006 · Neuropathology and Applied Neurobiology
  3. Humoral innate immunity at the crossroad between microbe and matrix recognition: The role of PTX3 in tissue damage
    Andrea Doni, Giovanna D’Amico, Diego Morone, Alberto Mantovani, Cecília Garlanda · 2016 · Seminars in Cell and Developmental Biology
  4. Accumulation and expression of serum amyloid P component in human atherosclerotic lesions
    Zhi-Qing Song, L. Cai, Ling Guo, Yoshitane Tsukamoto, C. Yutani, Xiang-An Li · 2010 · Atherosclerosis
  5. Search for Amyloid-Binding Proteins by Affinity Chromatography
    Miguel Calero, Agueda A. Rostagno, Jorge A. Ghiso · 2012 · Methods in molecular biology
  6. Molecular mechanisms and emerging therapies in wild-type transthyretin amyloid cardiomyopathy
    Danni Wu, Wei Chen · 2024 · Heart Failure Reviews
  7. Regulation of proteins mediating neurodegeneration in experimental autoimmune encephalomyelitis and multiple sclerosis
    Archana M. Jastorff, K. Haegler, G. Maccarrone, F. Holsboer, F. Weber, T. Ziemssen, C. Turck · 2009 · PROTEOMICS - Clinical Applications
  8. Brain Serum Amyloid P Levels are Reduced in Individuals that Lack Dementia While Having Alzheimer’s Disease Neuropathology
    Jeffrey R. Crawford, Nicole L. Bjorklund, Giulio Taglialatela, Richard H. Gomer · 2011 · Neurochemical Research
  9. Amyloid and the GI tract
    P. Sattianayagam, P. Hawkins, J. Gillmore · 2009 · Expert Review of Gastroenterology & Hepatology
  10. Ligand-assisted Aggregation of Proteins
    J. Ho, P. Kitov, E. Paszkiewicz, J. Sadowska, D. Bundle, K. Ng · 2005 · Journal of Biological Chemistry
  11. Multifaceted anti-amyloidogenic and pro-amyloidogenic effects of C-reactive protein and serum amyloid P component in vitro
    Daisaku Ozawa, Ryo Nomura, Palma Patrizia Mangione, Kazuhiro Hasegawa, Tadakazu Okoshi, Riccardo Porcari, Vittorio Bellotti, Hironobu Naiki · 2016 · Scientific Reports
  12. Pentraxins and Alzheimer's disease: At the interface between biomarkers and pharmacological targets
    Cecilia Osera, Alessia Pascale, Marialaura Amadio, Letizia Venturini, Stefano M. Govoni, Giovanni Ricevuti · 2011 · Ageing Research Reviews
  13. Crohn's disease and secondary amyloidosis: early complication? A case report and review of the literature.
    T. Basturk, Ayşim Ozağari, Tulin Ozturk, R. Kuşaslan, A. Unsal · 2009 · Journal of renal care
  14. Characterization of heparin binding by a peptide from amyloid P component using capillary electrophoresis, surface plasmon resonance and isothermal titration calorimetry.
    M. Hernaiz, L. Lebrun, Yi Wu, J. W. Sen, R. Linhardt, N. Heegaard · 2002 · European Journal of Biochemistry
  15. Immune Response in the Critically Ill
    J. Marshall, J. Cohen · 2002 · Update in Intensive Care Medicine
  16. Pharmacological removal of serum amyloid P component from intracerebral plaques and cerebrovascular Aβ amyloid deposits<i>in vivo</i>
    Al-Shawi, Raya, Tennent, Glenys A., Millar, David J., Richard-Londt, Angela, Brandner, Sebastian, Werring, David J., Simons, J. Paul, Pepys, Mark B. · 2016 · Open Biology
  17. Serum amyloid P component induces neuronal apoptosis and beta-amyloid immunoreactivity.
    Z. Urbányi, L. Laszlo, T. Tomasi, E. Tóth, Éva Mekes, M. Sass, T. Pázmány · 2003 · Brain Research
  18. Treatment of amyloidosis and the rheumatologist. State of the art and perspectives for the future.
    G. Husby · 1998 · Scandinavian Journal of Rheumatology
  19. Mechanisms of amyloid fibril formation
    Nikita V. Dovidchenko, Е. И. Леонова, Oxana V. Galzitskaya · 2014 · Biochemistry (Moscow)
  20. Serum amyloid P component induces TUNEL-positive nuclei in rat brain after intrahippocampal administration
    Zoltán Urbányi, Miklós Sass, Judit Laszy, Viktor Takács, István Gyertyán, Tamás Pázmány · 2007 · Brain Research
  21. Inflammation-Responsive Transcription Factor SAF-1 Activity Is Linked to the Development of Amyloid A Amyloidosis
    A. Ray, A. Shakya, Deepak Kumar, M. Benson, B. K. Ray · 2006 · Journal of Immunology
  22. Inhibition of the second phase of amyloidogenesis in a mouse model by a single-dose colchicine regimen.
    S. Shtrasburg, M. Pras, R. Gal, M. Salai, A. Livneh · 2001 · Journal of Laboratory and Clinical Medicine
  23. Expression of Mouse Apolipoprotein SAA1.1 in CE/J Mice: Isoform-Specific Effects on Amyloidogenesis
    Jin Yu, Hong Zhu, Jun-Tao Guo, F. D. de Beer, M. Kindy · 2000 · Laboratory Investigation
  24. Novel Pharmacological Strategies in Amyloidosis
    H. Lachmann, P. Hawkins · 2003 · Nephron Clinical Practice
  25. Mice lacking serum amyloid P component do not necessarily develop severe autoimmune disease.
    Makoto Soma, T. Tamaoki, H. Kawano, S. Ito, Mihoko Sakamoto, Y. Okada, Y. Ozaki, S. Kanba, Yoshiki Hamada, Tokuhiro Ishihara et al. · 2001 · Biochemical and Biophysical Research Communications - BBRC
  26. Proteomic Analysis of Amyloid Corneal Aggregates from TGFBI-H626R Lattice Corneal Dystrophy Patient Implicates Serine-Protease HTRA1 in Mutation-Specific Pathogenesis of TGFBIp.
    Anandalakshmi Venkatraman, Bamaprasad Dutta, E. Murugan, P. Hao, Rajamani Lakshminaryanan, Anita Chan Sook Yee, K. Pervushin, Siu-Kwan Sze, J. Mehta · 2017 · Journal of Proteome Research
  27. Amyloid and inflammation
    P. Gorevic · 2013 · Proceedings of the National Academy of Sciences of the United States of America
  28. Preferential association of serum amyloid P component with fibrillar deposits in familial British and Danish dementias: similarities with Alzheimer's disease.
    A. Rostagno, T. Lashley, Douglas Ng, J. Meyerson, H. Braendgaard, G. Plant, M. Bojsen-Møller, J. Holton, B. Frangione, T. Révész et al. · 2007 · Journal of Neurological Sciences
  29. The in vivo expression of actin/salt-resistant hyperactive DNase I inhibits the development of anti-ssDNA and anti-histone autoantibodies in a murine model of systemic lupus erythematosus
    Anthony P. Manderson, F. Carlucci, P. Lachmann, R. Lazarus, R. Festenstein, H. Cook, M. Walport, M. Botto · 2006 · Arthritis Research & Therapy
  30. Apolipoprotein E genotype, islet amyloid deposition and severity of Type 2 diabetes
    D.S Powell, H Maksoud, SOPHIE B. P. CHARGÉ, J.H Moffitt, M Desai, R.L Da Silva Fihlo, Andrew Tym Hattersley, IRENE M. STRATTON, David Richard Matthews, J Lévy et al. · 2003 · Diabetes Research and Clinical Practice
  31. Dynamic of β2‐Microglobulin Fibril Formation and Reabsorption: The Role of Proteolysis
    V. Bellotti, M. Gallieni, S. Giorgetti, D. Brancaccio · 2001 · Seminars in dialysis
  32. Amyloid persistence in decellularized liver: biochemical and histopathological characterization
    G. Mazza, J. Simons, R. Al-Shawi, S. Ellmerich, L. Urbani, S. Giorgetti, G. Taylor, J. Gilbertson, A. Hall, W. Al-Akkad et al. · 2015 · Amyloid: Journal of Protein Folding Disorders
  33. Early pathogenesis of cardiac amyloid deposition in senile systemic amyloidosis: close relationship between amyloid deposits and the basement membranes of myocardial cells
    M. Sawabe, A. Hamamatsu, Tateki Ito, T. Arai, Kumiko Ishikawa, K. Chida, N. Izumiyama, N. Honma, K. Takubo, M. Nakazato · 2003 · Virchows Archiv
  34. Extracellular Chaperones
    Rebecca A. Dabbs, Amy R. Wyatt, Justin J. Yerbury, Heath W. Ecroyd, Mark R. Wilson · 2011 · Topics in current chemistry
  35. Serum amyloid P component: Structure, biological activity, and application in diagnosis and treatment of immune-associated diseases
    Haixia Wang, Yadan Nie, Zuoli Sun, Yi He, Jian Yang · 2024 · Molecular Immunology
  36. Understanding autoimmunity: The ion channel perspective
    Anantha Maharasi Ramakrishnan, Kavitha Sankaranarayanan · 2016 · Autoimmunity Reviews
  37. Localization of Human Serum Amyloid P Component and Heparan Sulfate Proteoglycan in In Vitro‐Formed Aβ Fibrils
    Holm Nielsen, Nybo, Junker, Toftedal Hansen, Rasmussen, Svehag · 2000 · Scandinavian Journal of Immunology
  38. Serum Amyloid P and a Dendritic Cell–Specific Intercellular Adhesion Molecule-3–Grabbing Nonintegrin Ligand Inhibit High-Fat Diet–Induced Adipose Tissue and Liver Inflammation and Steatosis in Mice
    Pilling, Darrell, Cox, Nehemiah, Thomson, Megan A., Karhadkar, Tejas R., Gomer, Richard H. · 2019 · The American Journal of Pathology
  39. Primary localized gastric amyloidosis: A scoping review of the literature from clinical presentations to prognosis
    Xin-Yu Lin, Dan Pan, Li-Xuan Sang, B. Chang · 2021 · World Journal of Gastroenterology
  40. The Major Acute-Phase Protein, Serum Amyloid P Component, in Mice Is Not Involved in Endogenous Resistance against Tumor Necrosis Factor Alpha-Induced Lethal Hepatitis, Shock, and Skin Necrosis
    W. Van Molle, T. Hochepied, P. Brouckaert, C. Libert · 2000 · Infection and Immunity
  41. Inhibition of TTR Aggregation-Induced Cell Death – A New Role for Serum Amyloid P Component
    Karin Andersson, Malgorzata Pokrzywa, I. Dacklin, E. Lundgren · 2013 · PLoS ONE
  42. Congo Red Inhibits Proteoglycan and Serum Amyloid P Binding to Amyloid β Fibrils
    R. Gupta-Bansal, K. Brunden · 1998 · Journal of Neurochemistry
  43. Serum amyloid P secreted by bone marrow adipocytes drives skeletal amyloidosis
    Kumar, Surendra, Song, Kangping, Wang, Jiekang, Baghel, Meghraj Singh, Zeng, Yixiang, Shen, Ke, Zheng, Junying, Crane, Janet, Demehri, Shadpour, Gao, Peisong et al. · 2025 · Nature Aging
  44. Complex formation with pentraxin-2 regulates factor X plasma levels and macrophage interactions.
    V. Muczynski, G. Aymé, V. Regnault, M. Vasse, D. Borgel, P. Legendre, Amine Bazaa, Amélie Harel, Cécile Loubière, P. Lenting et al. · 2017 · Blood
  45. Normal circulating serum amyloid P component concentration in systemic sclerosis.
    G. Tennent, M. Dziadzio, E. Triantafillidou, P. Davies, J. Gallimore, C. Denton, M. Pepys · 2007 · Arthritis & Rheumatism
  46. Influenza Virus Infection is not Affected by Serum Amyloid P Component
    J. Herbert, W. Hutchinson, J. Carr, J. Ives, R. Jakob-Roetne, K. Yamamura, Misao Suzuki, M. Pepys · 2002 · Molecular Medicine
  47. Generalized AA-amyloidosis in a 58-year-old Caucasian woman with an 18-month history of gastrointestinal tuberculosis
    C. Röcken, D. Radun, B. Glasbrenner, P. Malfertheiner, A. Roessner · 1999 · Virchows Archiv
  48. Anti-Pentraxin Antibodies in Autoimmune Diseases: Bystanders or Pathophysiological Actors?
    Benoît Brilland, Emeline Vinatier, J. Subra, P. Jeannin, J. Augusto, Y. Delneste · 2021 · Frontiers in Immunology
  49. Nanomaterial synthesis, an enabler of amyloidosis inhibition against human diseases
    Nicholas Andrikopoulos, Yuhuan Li, Luca Cecchetto, Aparna Nandakumar, Tatiana Da Ros, Thomas Paul Davis, Kelly Velonia, Pu Chun Ke · 2020 · Nanoscale
  50. Suggestive linkage of familial primary cutaneous amyloidosis to a locus on chromosome 1q23
    Ming-Hsien Lin, Ding-Dar Lee, Chi-Hung Lin, C.-Y. Huang, C. Wong, Yuh-Lih Chang, Han-Nan Liu, Kwang-Jen Hsiao, Shih-Feng Tsai · 2005 · British Journal of Dermatology
  51. Inherited cardiomyopathies—Novel therapies
    Dror B. Leviner, Edith Hochhauser, Michael Arad · 2015 · Pharmacology & Therapeutics
  52. Disappearance of immunoglobulins from persistent renal amyloid deposits following stem cell transplantation for heavy-and light-chain amyloidosis.
    S. Safadi, Ahmed Saad, P. Quint, S. Sethi, N. Leung, Paul J. Kurtin, S. Nasr · 2015 · Nephrology, Dialysis and Transplantation
  53. Invasive candidiasis: new insights presaging new therapeutic approaches?
    M. Pepys · 2012 · Journal of Infectious Diseases
  54. Regulation of B cell tolerance by 129-derived chromosome 1 loci in C57BL/6 mice
    L. Fossati-Jimack, J. Cortes-Hernandez, P. Norsworthy, H. T. Cook, M. Walport, M. Botto · 2008 · Arthritis & Rheumatism
  55. Protein Misfolding Disorders and Rational Design of Antimisfolding Agents
    Lisbell D. Estrada, June Yowtak, Claudio A. Soto · 2006 · Humana Press eBooks
  56. Complement-pentraxins synergy: Navigating the immune battlefield and beyond
    Ying Jie Ma, Raffaella Parente, Hang Zhong, Yi Sun, Cecília Garlanda, Andrea Doni · 2023 · Biomedicine & Pharmacotherapy
  57. Complementary Roles of Short and Long Pentraxins in the Complement-Mediated Immune Response to Aspergillus fumigatus Infections
    Raffaella Parente, Valentina Possetti, M. Erreni, F. D’Autilia, B. Bottazzi, C. Garlanda, A. Mantovani, A. Inforzato, A. Doni · 2021 · Frontiers in Immunology
  58. Glycosaminoglycans inhibit neurodegenerative effects of serum amyloid P component in vitro.
    Z. Urbányi, Erika Forrai, M. Sárvári, I. Likó, J. Illés, T. Pázmány · 2005 · Neurochemistry International
  59. Ocular ball bullet injury: detection of gonioscopically unrecognisable cyclodialysis by ultrasound biomicroscopy
    S. Endo, Gentei Mitsukawa, S. Fujisawa, Yoshihiro Hashimoto, N. Ishida, Tatsuo Yamaguchi · 1999 · British Journal of Ophthalmology
  60. Serpents on the road to dementia and death
    Konrad T. Beyreuther, Colin Louis Masters · 1997 · Nature Medicine
  61. Endoscopic and pathological characteristics of gastrointestinal amyloidosis: a retrospective analysis
    Zhan-Yue Niu, Yan-Fei Lang, Yu-Ting Shen, He-Jun Zhang, Yan Xue, Shigang Ding · 2025 · BMC Gastroenterology
  62. Recombinant human serum amyloid P component from Pichia pastoris: production and characterization.
    Susan C. Boysen, Berit Fogh-Schultz, I. Andersen, P. Højrup, J. Iversen, P. Wittenhagen, E. H. Nielsen, S. Svehag · 2004 · Protein Expression and Purification
  63. Diet, amyloid enhancing factor (AEF) and amyloidogenesis: an hypothesis.
    E. Cathcart, R. Elliott-Bryant · 1999 · Amyloid: Journal of Protein Folding Disorders
  64. Serum amyloid P component (not Serum Amyloid Protein)
    Pepys, M.B. · 1999 · Nature Medicine
  65. Genetic evidence for serum amyloid P component as a drug target in neurodegenerative disorders
    Schmidt, A. Floriaan, Finan, Chris, Chopade, Sandesh, Ellmerich, Stephan, Rossor, Martin N., Hingorani, Aroon D., Pepys, Mark B. · 2024 · Open Biology
  66. Amyloids in Site-Specific Autoimmune Reactions and Inflammatory Responses
    Yanmei Huang, Xuezhi Hong, Jian Xing Shen, Li-Jun Geng, Yan-Hong Pan, Wei Ling, Hai‐Lu Zhao · 2020 · Frontiers in Immunology
  67. The pentraxin serum amyloid P component is found in the male genital tract and attached to spermatozoa.
    J. Malm, A. Sonesson, J. Hellman, A. Bjartell, B. Frohm, A. Hillarp · 2008 · International Journal of Andrology
  68. Renal amyloidosis as a late complication of Crohn's disease: a case report and review of the literature from Japan.
    O. Saitoh, K. Kojima, Tsutomu Teranishi, K. Nakagawa, M. Kayazawa, M. Nanri, Y. Egashira, I. Hirata, K. Katsu · 2000 · World Journal of Gastroenterology
  69. Extracellular Chaperones and Amyloids
    Mark R. Wilson, Justin J. Yerbury, Stephen Poon · 2008 · Springer eBooks
  70. Monoclonal Gammopathies and the Kidney
    G. Touchard, P. Aucouturier, O. Hermine, P. Ronco · 2003 · Springer Netherlands
  71. Insights from the in silico structural, functional and phylogenetic characterization of canine lysyl oxidase protein
    Afnan Saleem, Shiveeli Rajput · 2020 · Journal of Genetic Engineering and Biotechnology
  72. Serum Amyloid P-Component Prevents Cardiac Remodeling in Hypertensive Heart Disease
    Stephen James Horgan, Chris J Watson, Nadezhda Glezeva, P. Collier, Roisín Neary, Isaac Tea, Niamh Corrigan, Mark T. Ledwidge, Kenneth McDonald, John Andrew Baugh · 2015 · Journal of Cardiovascular Translational Research
  73. Evidence for an extended interacting surface between beta-amyloid and serum amyloid P component.
    I. Likó, M. Mâk, É. Klement, É. Hunyadi-Gulyás, T. Pázmány, K. Medzihradszky, Z. Urbányi · 2007 · Neuroscience Letters
  74. Familial amyloidosis of the Finnish type
    A. Mearza, M. Ajao, D. Etchells · 1999 · British Journal of Ophthalmology
  75. [44] A mouse model for serum amyloid A amyloidosis
    Mark S. Kindy, Frederick C. de Beer · 1999 · Methods in enzymology on CD-ROM/Methods in enzymology
  76. Structurally Altered, Not Wild-Type, Pentameric C-Reactive Protein Inhibits Formation of Amyloid-β Fibrils
    Donald Neba Ngwa, Alok Agrawal · 2022 · The Journal of Immunology
  77. Serum amyloid P component in mink, a non-glycosylated protein with affinity for phosphorylethanolamine and phosphorylcholine
    L. Omtvedt, T. Wien, Theresa Myran, K. Sletten, G. Husby · 2004 · Amyloid: Journal of Protein Folding Disorders
  78. Serological evidence for an inflammatory response in murine scrapie.
    J. Coe, R. Race, Mary J. Ross · 2001 · Journal of Infectious Diseases
  79. Gastroesophageal reflux and Helicobacter pylori: a review.
    F. Pace, G. Porro · 2000 · World Journal of Gastroenterology
  80. Survey of amyloidosis cases among different free-living wild and zoo animals
    Hailey B. Penticoff, H. Hipkiss, Ashley A. Hetak, D. Agnew, J. Fortin · 2021 · Amyloid: Journal of Protein Folding Disorders
  81. Monitoring systemic amyloidosis using MRI measurements of the extracellular volume fraction
    A. Campbell-Washburn, A. Price, S. Ellmerich, J. Simons, R. Al-Shawi, T. Kalber, Rupinder Ghatrora, P. Hawkins, J. Moon, R. Ordidge et al. · 2013 · Amyloid: Journal of Protein Folding Disorders
  82. Immunoradiometric assay for human serum amyloid P component.
    D. Millar, W. Hutchinson, M. Pepys · 2011 · JIM - Journal of Immunological Methods
  83. Serum Amyloid P Component Does Not Circulate in Complex with C4‐Binding Protein, Fibronectin or Any Other Major Protein Ligand
    J. W. Sen, N. Heegaard · 2002 · Scandinavian Journal of Immunology
  84. Amyloid Diseases at the Molecular Level: General Overview and Focus on AL Amyloidosis
    M. Nuvolone, G. Palladini, G. Merlini · 2012
  85. The Acute Phase Response and Enhancing Resistance to Bacterial Infection
    M. Noursadeghi, J. Cohen · 2002
  86. Multi-organ structural homogeneity of amyloid fibrils in ATTRv-T60A amyloidosis patients, revealed by Cryo-EM
    María del Carmen Fernández-Ramírez, B. Nguyen, Preeti Singh, Shumaila Afrin, Bret M. Evers, Parker Basset, Lanie Wang, Maja Pękała, Yasmin Ahmed, Virender Singh et al. · 2024 · bioRxiv
  87. Identifying new molecular players in extracellular proteostasis
    Sandeep Satapathy, Mark R. Wilson · 2021 · Biochemical Society Transactions
  88. Serum Amyloid P and Endocrine Markers in a Cohort of Obese Children
    Mehwish Anwer, M. Iqbal · 2018 · Indian journal of endocrinology and metabolism
  89. Serum amyloid P component and cardiovascular disease: is there a sensible link?
    W. Koenig · 2007 · Arteriosclerosis, Thrombosis and Vascular Biology
  90. Use of genetically altered mice to study the role of serum amyloid P component in amyloid deposition
    S. Maeda · 2003 · Amyloid: Journal of Protein Folding Disorders
  91. Homozygous serum amyloid P component-deficiency does not enhance regression of AA amyloid deposits
    Ikuo Usui, H. Kawano, S. Ito, Yoshiki Hamada, T. Ishihara, S. Maeda · 2001 · Amyloid: Journal of Protein Folding Disorders
  92. Inhibition of Amyloid A Amyloidogenesis in Vivo and in Tissue Culture by 4-Deoxy Analogues of Peracetylated 2-Acetamido-2-Deoxy-α- and β-d-Glucose
    Robert Kisilevsky, Walter A. Szarek, John B. Ancsin, Elena C. Elimova, Sandra Marone, Shridhar Bhat, Ali Berkin · 2004 · American Journal Of Pathology
  93. Pentraxins in invertebrates and vertebrates: From structure, function and evolution to clinical applications
    Yuying Wang, Wei Chen, Shuo Ding, Wenjun Wang, Changliu Wang · 2023 · Developmental & Comparative Immunology
  94. Role of apoE in conformation-prone diseases and atherosclerosis
    Alexander D. Dergunov · 2006 · Biochemistry (Moscow)
  95. Physiopathologie des amyloses
    Grateau Gilles · 2000
  96. Mechanisms of thalidomide teratogenicity
    V. Guenzler · 1999 · Nature Medicine
  97. Pentraxins: The L-Type Lectins and the C-Reactive Protein as a Cardiovascular Risk
    G. Gupta · 2012 · Springer eBooks
  98. Human iPSC‐Derived Mononuclear Phagocytes Improve Cognition and Neural Health across Multiple Mouse Models of Aging and Alzheimer's Disease
    V. Moser, Luz Jovita Dimas-Harms, Rachel M. Lipman, Jake Inzalaco, Shaughn Bell, M. Alcântara, Erikha Valenzuela, George Lawless, Simion D. Kreimer, Sarah J. Parker et al. · 2025 · Advancement of science
  99. Harnessing PoSAP, a serum amyloid P component in Japanese flounder (Paralichthys olivaceus) for superior antibacterial immunity in teleost fish
    Sheng-han Gao, Jia-qi Sun, Kun-yu Zhao, Gang Li, Jian Zhang, Xue-peng Li · 2025 · Aquaculture
  100. [Transthyretin-related amyloidotic cardiomyopathy: looking for the etiological treatment].
    Simone Longhi, C. Gagliardi, Agnese Milandri, L. Manuzzi, Claudio Rapezzi · 2014 · Giornale italiano di cardiologia